WCM
NVCR icon

Weld Capital Management’s NovoCure NVCR Stock Holding History

Weld Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,193
Closed -$265K – 131
2021
Q2 		$265K Buy
+1,193
New +$232K 0.27% 161
2019
Q3 		– Sell
-4,850
Closed -$307K – 930
2019
Q2 		$307K Buy
+4,850
New +$246K 0.06% 539

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Weld Capital Management's NVCR Position: Q3 2021 in Review

Weld Capital Management sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,193 shares — an estimated $265K sold.

Weld Capital Management first reported a position in NVCR in Q2 2019 and held it in 2 quarters. The position peaked at $307K in Q2 2019. 318 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Weld Capital Management reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Weld Capital Management sold 1,193 NovoCure shares in Q3 2021, an estimated $265K.
  • Weld Capital Management first reported a position in NovoCure in Q2 2019 and held it in 2 quarters.
  • Weld Capital Management's NovoCure position peaked at $307K in Q2 2019.
  • 318 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Weld Capital Management's 13F filing for Q3 2021.